MedPath

The efficacy of ramelteon to prevent postoperative delirium after general anesthesia in the elderly: a randomized placebo controlled trial

Not Applicable
Conditions
postoperative delirium
Registration Number
JPRN-UMIN000028436
Lead Sponsor
Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology
Brief Summary

The stratified log rank test showed no significant difference between ramelteon and placebo to prevent postoperative delirium in the elderly undergoing abdominal or thoracic surgery ( p = 0.596 ). The findings of this randomized double-blind placebo-controlled trial do not support the effect of ramelteon to prevent postoperative delirium.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
103
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are delirious on registry Patients who are currently taking ramelteon Patients who have a previous adverse reaction to ramelteon Patients who take medicine contraindicated to be coadministered with ramelteon Patients with lactose intolerance Patients who are considered non per os on postoperative day 1 Patients who are considered to be discharged within postoperative day 6 Patients who have a score less than or equal to 10 on the Mini Mental State Examination Patients who have severe hepatic damage Patients with known Dementia with Lewy bodies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath